Biodexa Pharmaceticals (BDRX) — Net Asset Quality Index
Biodexa Pharmaceticals (BDRX) has a Net Asset Quality Index of 62.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $18.15 Million minus total liabilities of $6.76 Million yields net assets of $11.38 Million. A higher index indicates a stronger, lower-leverage balance sheet. See how many days can Biodexa Pharmaceticals fund operations to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Biodexa Pharmaceticals Net Asset Quality Index Over Time (2012–2025)
This chart shows how Biodexa Pharmaceticals's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the index stands at 62.7%, representing net assets of $11.38 Million against total assets of $18.15 Million USD. Explore Biodexa Pharmaceticals cash conversion from operations to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Biodexa Pharmaceticals (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Biodexa Pharmaceticals from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Biodexa Pharmaceticals.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 62.7% | $11.38 Million | $18.15 Million | $6.76 Million | ▲ +6.4 pp |
| 2024 | 56.3% | $8.32 Million | $14.78 Million | $6.46 Million | ▲ +11.9 pp |
| 2023 | 44.4% | $4.68 Million | $10.54 Million | $5.86 Million | ▼ -12.9 pp |
| 2022 | 57.2% | $3.16 Million | $5.53 Million | $2.36 Million | ▼ -23.7 pp |
| 2021 | 80.9% | $10.45 Million | $12.91 Million | $2.46 Million | ▲ +12.5 pp |
| 2020 | 68.4% | $6.72 Million | $9.82 Million | $3.10 Million | ▲ +5.1 pp |
| 2019 | 63.3% | $19.56 Million | $30.89 Million | $11.34 Million | ▼ -19.5 pp |
| 2018 | 82.8% | $16.92 Million | $20.44 Million | $3.52 Million | ▲ +12.3 pp |
| 2017 | 70.4% | $34.68 Million | $49.22 Million | $14.55 Million | ▼ -10.2 pp |
| 2016 | 80.7% | $45.72 Million | $56.69 Million | $10.96 Million | ▲ +7.4 pp |
| 2015 | 73.2% | $46.89 Million | $64.04 Million | $17.15 Million | ▼ -16.8 pp |
| 2014 | 90.0% | $41.99 Million | $46.66 Million | $4.67 Million | ▲ +75.3 pp |
| 2013 | 14.7% | $760.00K | $5.17 Million | $4.41 Million | ▲ +243.9 pp |
| 2012 | -229.2% | $-8.28 Million | $3.61 Million | $11.89 Million | — |